Claims for Patent: 11,004,545

✉ Email this page to a colleague

Summary for Patent: 11,004,545

Title:	Clinical effect of pharmaceutical products using communication tool integrated with compound of several pharmaceutical products
Abstract:	A combination of N>1 substances with pharmaceutical activity against at least one medical condition for treating the medical condition with a program including instructions causing a computer to perform a method including:
Inventor(s):	Cederlund Johan
Assignee:	INTELLECTUAL PROPERTY ENABLER STOCKHOLM AB
Application Number:	US16160519
Patent Claims:

Details for Patent 11,004,545

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	June 14, 1996	⤷ Get Started Free	2038-10-15
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	August 06, 1998	⤷ Get Started Free	2038-10-15
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	September 06, 2007	⤷ Get Started Free	2038-10-15
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	June 06, 2017	⤷ Get Started Free	2038-10-15
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	November 15, 2019	⤷ Get Started Free	2038-10-15
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	June 07, 2000	⤷ Get Started Free	2038-10-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.